Advanced search
Publication Cover
Cancer Biology & Therapy Volume 13, 2012 - Issue 5
Submit an article Journal homepage
2,483
Views
111
CrossRef citations to date
0
Altmetric
Research Paper

MiRNA-21

A biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non-small cell lung cancer

Wen Gao Department of Oncology; The First Affiliated Hospital of Nanjing Medical University; Nanjing, China;; These authors contributed equally to this workCorrespondence[email protected] [email protected]
,
Xiao Lu Department of Oncology; Changshu No.1 People’s Hospital; Changshu, China;; These authors contributed equally to this work
,
Lingxiang Liu Department of Oncology; The First Affiliated Hospital of Nanjing Medical University; Nanjing, China;
,
JIng Xu
,
Dongjie Feng
&
Yongqian Shu Department of Oncology; The First Affiliated Hospital of Nanjing Medical University; Nanjing, China;Correspondence[email protected] [email protected]
Pages 330-340 | Received 03 Aug 2011, Accepted 15 Dec 2011, Published online: 01 Mar 2012

Citations (111)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Xiaodan Liu, Ziyan Luo, Hongxia Peng, Hua Jiang & Ling Xu. (2016) Prognostic role of miR-9 expression in various human malignant neoplasms: a meta-analysis. OncoTargets and Therapy 9, pages 3039-3047.
Read now
Athina Markou, Martha Zavridou & Evi S Lianidou. (2016) miRNA-21 as a novel therapeutic target in lung cancer. Lung Cancer: Targets and Therapy 7, pages 19-27.
Read now
Kun Liu, Hong-Lin Chen, Ming-Ming Gu & Qing-Sheng You. (2016) NOB1 expression predicts early response to cisplatin-based chemotherapy in patients with advanced non-small cell lung cancer. Journal of Chemotherapy 28:3, pages 225-229.
Read now
PJ Frederick, HN Green, JS Huang, ME Egger, HB Frieboes, WE Grizzle & LR McNally. (2013) Chemoresistance in ovarian cancer linked to expression of microRNAs. Biotechnic & Histochemistry 88:7, pages 403-409.
Read now
Liu Hong, Yu Han, Yujie Zhang, Hongwei Zhang, Qingchuan Zhao, Kaichun Wu & Daiming Fan. (2013) MicroRNA-21: a therapeutic target for reversing drug resistance in cancer. Expert Opinion on Therapeutic Targets 17:9, pages 1073-1080.
Read now
Xiaoxia Liu, Li Liu, Qian Xu, Ping Wu, Xialin Zuo & Aimin Ji. (2012) MicroRNA as a novel drug target for cancer therapy. Expert Opinion on Biological Therapy 12:5, pages 573-580.
Read now

Articles from other publishers (105)

Daria Molodtsova, Denis V. Guryev & Andreyan N. Osipov. (2023) Composition of Conditioned Media from Radioresistant and Chemoresistant Cancer Cells Reveals miRNA and Other Secretory Factors Implicated in the Development of Resistance. International Journal of Molecular Sciences 24:22, pages 16498.
Crossref
Dariush Shanehbandi, Milad Asadi, Ensiyeh Seyedrezazadeh, Venus Zafari, Najibeh Shekari, Mortaza Akbari, Leila Rahbarnia & Habib Zarredar. (2023) MicroRNA-Based Biomarkers in Lung Cancer: Recent Advances and Potential Applications. Current Molecular Medicine 23:7, pages 648-667.
Crossref
Osama Sweef, Elsayed Zaabout, Ahmed Bakheet, Mohamed Halawa, Ibrahim Gad, Mohamed Akela, Ehab Tousson, Ashraf Abdelghany & Saori Furuta. (2023) Unraveling Therapeutic Opportunities and the Diagnostic Potential of microRNAs for Human Lung Cancer. Pharmaceutics 15:8, pages 2061.
Crossref
Roberto Cuttano, Miriam Kuku Afanga & Fabrizio Bianchi. (2022) MicroRNAs and Drug Resistance in Non-Small Cell Lung Cancer: Where Are We Now and Where Are We Going. Cancers 14:23, pages 5731.
Crossref
Qi Wang, Wenyong Li, Juan Xia, Hai Wu, Lijun Wu & Jianguo Xu. (2022) Stepwise tuning of a molecular beacon coupled Y probe regulates ternary DNA nanomachine-based microRNA determination. Sensors and Actuators B: Chemical 363, pages 131858.
Crossref
Wei Wang, Xinyao Li, Chengfei Liu, Xin Zhang, Ying Wu, Mingxin Diao, Siyu Tan, Shubin Huang, Yin Cheng & Tao You. (2022) MicroRNA-21 as a diagnostic and prognostic biomarker of lung cancer: a systematic review and meta-analysis. Bioscience Reports 42:5.
Crossref
Shaohua Xu, Yueliang Wang, Yuanyuan Yao, Lifen Chen, Jiahui Xu, Bin Qiu & Longhua Guo. (2022) Toehold-mediated strand displacement coupled with single nanoparticle dark-field microscopy imaging for ultrasensitive biosensing. Nanoscale 14:9, pages 3496-3503.
Crossref
Lan Lin, Yingying Zhang, Qiongying Wei, Hongguang Lin, Xiaoping Li, Mei-E Yu, Jie Wang, Zhenghui Huang & Dan Xue. (2022) Structure and function encoding of a bidirectional activatable synergetic DNA machine for speeded and ultrasensitive determination of microRNAs. Talanta 238, pages 123037.
Crossref
Santosh Kumar, Naveen Kumar Vishvakarma & Ajay Kumar. 2022. Clinical Applications of Non-Coding RNAs in Cancer. Clinical Applications of Non-Coding RNAs in Cancer 141 175 .
Priya Mondal & Syed Musthapa Meeran. 2022. Epigenetics in Precision Medicine. Epigenetics in Precision Medicine 513 542 .
Michela Saviana, Giulia Romano, Patricia Le, Mario Acunzo & Patrick Nana-Sinkam. (2021) Extracellular Vesicles in Lung Cancer Metastasis and Their Clinical Applications. Cancers 13:22, pages 5633.
Crossref
Min Liu, Fei Mo, Xiaohan Song, Yun He, Yan Yuan, Jiaoyan Yan, Ye Yang, Jian Huang & Shu Zhang. (2021) Exosomal hsa-miR-21-5p is a biomarker for breast cancer diagnosis. PeerJ 9, pages e12147.
Crossref
Nahid ArghianiMaryam M. Matin. (2021) miR-21: A Key Small Molecule with Great Effects in Combination Cancer Therapy. Nucleic Acid Therapeutics 31:4, pages 271-283.
Crossref
Debora Olioso, Mario Caccese, Alessandra Santangelo, Giuseppe Lippi, Vittorina Zagonel, Giulio Cabrini, Giuseppe Lombardi & Maria Cristina Dechecchi. (2021) Serum Exosomal microRNA-21, 222 and 124-3p as Noninvasive Predictive Biomarkers in Newly Diagnosed High-Grade Gliomas: A Prospective Study. Cancers 13:12, pages 3006.
Crossref
Ye Sun, Wenjun Liu, Qiuyu Zhao, Ruiqi Zhang, Jianbo Wang, Pengyu Pan, Hai Shang, Chunying Liu & Chun Wang. (2021) Down-Regulating the Expression of miRNA-21 Inhibits the Glucose Metabolism of A549/DDP Cells and Promotes Cell Death Through the PI3K/AKT/mTOR/HIF-1α Pathway. Frontiers in Oncology 11.
Crossref
Yudong Wu, Qian Li, Renshuai Zhang, Xiaoli Dai, Wujun Chen & Dongming Xing. (2021) Circulating microRNAs: Biomarkers of disease. Clinica Chimica Acta 516, pages 46-54.
Crossref
Shen Zhong, Heiko Golpon, Patrick Zardo & Jürgen Borlak. (2021) miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer. Translational Research 230, pages 164-196.
Crossref
Ganglin Wang, Yanbin Guo, Yingbin Liu, Weihang Zhou & Guoping Wang. (2021) Algorithm-Assisted Detection and Imaging of microRNAs in Living Cancer Cells via the Disassembly of Plasmonic Core-Satellite Probes Coupled with Strand Displacement Amplification. ACS Sensors 6:3, pages 958-966.
Crossref
Rong Li, Yi-Xian Wen, Yan-Qing Geng, Yong-Jiang Zhou, Yue Zhang, Yu-Bin Ding, Xue-Mei Chen, Ru-Fei Gao, Jun-Lin He, Ying-Xiong Wang & Xue-Qing Liu. (2021) miR-21a inhibits decidual cell apoptosis by targeting Pdcd4. Genes & Diseases 8:2, pages 171-180.
Crossref
Tianjiao Geng, Patrick Pan, Euphemia Leung, Qi Chen, Larry Chamley & Zimei Wu. (2021) Recent Advancement and Technical Challenges in Developing Small Extracellular Vesicles for Cancer Drug Delivery. Pharmaceutical Research 38:2, pages 179-197.
Crossref
Felipe Bustamante, Maxs Méndez-Ruette, Ursula Wyneken, Luis Federico Bátiz & Roberto Henzi. 2021. Stress: Genetics, Epigenetics and Genomics. Stress: Genetics, Epigenetics and Genomics 179 193 .
Cecilia Pop-Bica, Sebastian Pintea, Lorand Magdo, Roxana Cojocneanu, Diana Gulei, Manuela Ferracin & Ioana Berindan-Neagoe. (2020) The Clinical Utility of miR-21 and let-7 in Non-small Cell Lung Cancer (NSCLC). A Systematic Review and Meta-Analysis. Frontiers in Oncology 10.
Crossref
Alexander T.H. Wu, Prateeti Srivastava, Vijesh Kumar Yadav, David T.W. Tzeng, Sitthichai Iamsaard, Emily Chia-Yu Su, Michael Hsiao & Ming-Che Liu. (2020) Ovatodiolide, isolated from Anisomeles indica, suppresses bladder carcinogenesis through suppression of mTOR/β-catenin/CDK6 and exosomal miR-21 derived from M2 tumor-associated macrophages. Toxicology and Applied Pharmacology 401, pages 115109.
Crossref
Diana Bautista-Sánchez, Cristian Arriaga-Canon, Abraham Pedroza-Torres, Inti Alberto De La Rosa-Velázquez, Rodrigo González-Barrios, Laura Contreras-Espinosa, Rogelio Montiel-Manríquez, Clementina Castro-Hernández, Verónica Fragoso-Ontiveros, Rosa María Álvarez-Gómez & Luis A. Herrera. (2020) The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics. Molecular Therapy - Nucleic Acids 20, pages 409-420.
Crossref
Sabrina Müller, Florian Janke, Steffen Dietz & Holger Sültmann. 2020. Tumor Liquid Biopsies. Tumor Liquid Biopsies 299 318 .
Yeseul Kim, Jongmin Sim, Hyunsung Kim, Seong Sik Bang, Seungyun Jee, Sungeon Park & Kiseok Jang. (2019) MicroRNA-374a Expression as a Prognostic Biomarker in Lung Adenocarcinoma. Journal of Pathology and Translational Medicine 53:6, pages 354-360.
Crossref
Michela Bottani, Giuseppe Banfi & Giovanni Lombardi. (2019) Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Common Solid Tumors: Focus on Lung, Breast, Prostate Cancers, and Osteosarcoma. Journal of Clinical Medicine 8:10, pages 1661.
Crossref
Ning Xie, Yuan‑Rong Liu, Yan‑Mei Li, Ya‑Nan Yang, Li Pan, Yu‑Bo Wei, Ping‑Yu Wang, You‑Jie Li & Shu‑Yang Xie. (2019) Cisplatin decreases cyclin D2 expression via upregulating miR‑93 to inhibit lung adenocarcinoma cell growth. Molecular Medicine Reports.
Crossref
Yusheng Yan, Shaobin Li, Suihai Wang, Pietro Rubegni, Linda Tognetti, Jiaqing Zhang & Lu Yan. (2018) Long noncoding RNA HAND2‐AS1 inhibits cancer cell proliferation, migration, and invasion in esophagus squamous cell carcinoma by regulating microRNA‐21 . Journal of Cellular Biochemistry 120:6, pages 9564-9571.
Crossref
Franziska Böttger, Tieneke B. Schaaij-Visser, Inge de Reus, Sander R. Piersma, Thang V. Pham, Remco Nagel, Ruud H. Brakenhoff, Erik Thunnissen, Egbert F. Smit & Connie R. Jimenez. (2019) Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction. Journal of Proteomics 196, pages 106-119.
Crossref
Sile Liu, Yuting Zhan, Jiadi Luo, Juan Feng, Junmi Lu, Hongmei Zheng, Qiuyuan Wen & Songqing Fan. (2019) Roles of exosomes in the carcinogenesis and clinical therapy of non-small cell lung cancer. Biomedicine & Pharmacotherapy 111, pages 338-346.
Crossref
Weronika Maria Szejniuk, Ana I. Robles, Tine McCulloch, Ursula Gerda Inge Falkmer & Oluf Dimitri Røe. (2018) Epigenetic predictive biomarkers for response or outcome to platinum-based chemotherapy in non-small cell lung cancer, current state-of-art. The Pharmacogenomics Journal 19:1, pages 5-14.
Crossref
Surya Kant Tripathi, Kamal Pandey, Munmun Panda & Bijesh K. Biswal. 2019. AGO-Driven Non-Coding RNAs. AGO-Driven Non-Coding RNAs 293 318 .
Bernhard Biersack. (2018) Relations between approved platinum drugs and non-coding RNAs in mesothelioma. Non-coding RNA Research 3:4, pages 161-173.
Crossref
Cecilia Bica-Pop, Roxana Cojocneanu-Petric, Lorand Magdo, Lajos Raduly, Diana Gulei & Ioana Berindan-Neagoe. (2018) Overview upon miR-21 in lung cancer: focus on NSCLC. Cellular and Molecular Life Sciences 75:19, pages 3539-3551.
Crossref
Jie Shen, Jianhua Zhang, Minhui Xiao, Junfeng Yang & Ningnan Zhang. (2018) miR-203 Suppresses Bladder Cancer Cell Growth and Targets Twist1. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 26:8, pages 1155-1165.
Crossref
Simone Anfossi, Anna Babayan, Klaus Pantel & George A. Calin. (2018) Clinical utility of circulating non-coding RNAs — an update. Nature Reviews Clinical Oncology 15:9, pages 541-563.
Crossref
Jun Chen, Chao Zhou, Junhe Li, Xiaojun Xiang, Ling Zhang, Jun Deng & Jianping Xiong. (2018) miR‑21‑5p confers doxorubicin resistance in gastric cancer cells by targeting PTEN and TIMP3. International Journal of Molecular Medicine.
Crossref
Yilun Sun, Peter G. Hawkins, Nan Bi, Robert T. Dess, Muneesh Tewari, Jason W.D. Hearn, James A. Hayman, Gregory P. Kalemkerian, Theodore S. Lawrence, Randall K. Ten Haken, Martha M. Matuszak, Feng-Ming Kong, Shruti Jolly & Matthew J. Schipper. (2018) Serum MicroRNA Signature Predicts Response to High-Dose Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics 100:1, pages 107-114.
Crossref
William C.S. Cho. 2018. IASLC Thoracic Oncology. IASLC Thoracic Oncology 129 136.e2 .
Simone Detassis, Margherita Grasso, Valerio Del Vescovo & Michela A. Denti. (2017) microRNAs Make the Call in Cancer Personalized Medicine. Frontiers in Cell and Developmental Biology 5.
Crossref
Antoine Legras, Nicolas Pécuchet, Sandrine Imbeaud, Karine Pallier, Audrey Didelot, Hélène Roussel, Laure Gibault, Elizabeth Fabre, Françoise Le Pimpec-Barthes, Pierre Laurent-Puig & Hélène Blons. (2017) Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer. Cancers 9:12, pages 101.
Crossref
Baoquan Liu, Fei Su, Mingwei Chen, Yue Li, Xiuying Qi, Jianbing Xiao, Xuemei Li, Xiangchen Liu, Wenlong Liang, Yafang Zhang & Jianguo Zhang. (2017) Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer. Human Pathology 64, pages 44-52.
Crossref
Karla A. Ruiz-Ceja & Yolanda I. Chirino. (2017) Current FDA-approved treatments for non-small cell lung cancer and potential biomarkers for its detection. Biomedicine & Pharmacotherapy 90, pages 24-37.
Crossref
Ming Qi, Dongmei Liu & Shuhong Zhang. (2017) MicroRNA-21 contributes to the discrimination of chemoresistance in metastatic gastric cancer. Cancer Biomarkers 18:4, pages 451-458.
Crossref
Mateusz Florczuk, Adam Szpechcinski & Joanna Chorostowska-Wynimko. (2017) miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives. Targeted Oncology 12:2, pages 179-200.
Crossref
Lihua Li & Zhaohui Luo. (2017) Dysregulated miR-27a-3p promotes nasopharyngeal carcinoma cell proliferation and migration by targeting Mapk10. Oncology Reports.
Crossref
Bernhard Biersack. (2017) Interactions between anticancer active platinum complexes and non-coding RNAs/microRNAs. Non-coding RNA Research 2:1, pages 1-17.
Crossref
Xu-Hua Mao, Min Chen, Yan Wang, Pan-Gen Cui, Si-Bian Liu & Zei-Yong Xu. (2017) MicroRNA-21 regulates the ERK/NF-κB signaling pathway to affect the proliferation, migration, and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4, and PTEN. Molecular Carcinogenesis 56:3, pages 886-894.
Crossref
Xin Zhou, Wei Wen, Xia Shan, Wei Zhu, Jing Xu, Renhua Guo, Wenfang Cheng, Fang Wang, Lian-Wen Qi, Yan Chen, Zebo Huang, Tongshan Wang, Danxia Zhu, Ping Liu & Yongqian Shu. (2016) A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis. Oncotarget 8:4, pages 6513-6525.
Crossref
Alejandro Luarte, Pablo Cisternas, Ariel Caviedes, Luis Federico Batiz, Carlos Lafourcade, Ursula Wyneken & Roberto Henzi. (2017) Astrocytes at the Hub of the Stress Response: Potential Modulation of Neurogenesis by miRNAs in Astrocyte-Derived Exosomes. Stem Cells International 2017, pages 1-13.
Crossref
Jinghua Zhu, Yuhua Qi, Jianzhong Wu, Meiqi Shi, Jifeng Feng & Longbang Chen. (2016) Evaluation of plasma microRNA levels to predict insensitivity of patients with advanced lung adenocarcinomas to pemetrexed and platinum. Oncology Letters 12:6, pages 4829-4837.
Crossref
Alexios Matikas, Konstantinos N. Syrigos & Sofia Agelaki. (2016) Circulating Biomarkers in Non–Small-Cell Lung Cancer: Current Status and Future Challenges. Clinical Lung Cancer 17:6, pages 507-516.
Crossref
Yantao Du, Yichen Chen, Furong Wang & Liankun Gu. (2016) miR-137 plays tumor suppressor roles in gastric cancer cell lines by targeting KLF12 and MYO1C. Tumor Biology 37:10, pages 13557-13569.
Crossref
Antonello Di Paolo, Marzia Del Re, Iacopo Petrini, Giuseppe Altavilla & Romano Danesi. (2016) Recent advances in epigenomics in NSCLC: real-time detection and therapeutic implications. Epigenomics 8:8, pages 1151-1167.
Crossref
R Schreiber, R Mezencev, L V Matyunina & J F McDonald. (2016) Evidence for the role of microRNA 374b in acquired cisplatin resistance in pancreatic cancer cells. Cancer Gene Therapy 23:8, pages 241-245.
Crossref
Bárbara Filipa Adem, Nuno Ricardo Alves Bastos, Francisca Dias, Ana Luísa Teixeira & Rui Medeiros. (2016) miRNAs: mediators of ErbB family targeted therapy resistance. Pharmacogenomics 17:10, pages 1175-1187.
Crossref
Shih-Hsuan Chan & Lu-Hai Wang. (2015) Regulation of cancer metastasis by microRNAs. Journal of Biomedical Science 22:1.
Crossref
Igor Koturbash, William H Tolleson, Lei Guo, Dianke Yu, Si Chen, Huixiao Hong, William Mattes & Baitang Ning. (2015) microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessment. Biomarkers in Medicine 9:11, pages 1153-1176.
Crossref
Diana Sousa, Raquel T. Lima & M. Helena Vasconcelos. (2015) Intercellular Transfer of Cancer Drug Resistance Traits by Extracellular Vesicles. Trends in Molecular Medicine 21:10, pages 595-608.
Crossref
Erlin Sun, Lining Wang, Xiaodong Zhou, Chengquan Ma, Yan Sun, Mingde Lei, Bingxin Lu & Ruifa Han. (2015) Retracted Article: Graphene oxide/DNA-decorated electrode for the fabrication of microRNA biosensor. RSC Advances 5:85, pages 69334-69338.
Crossref
FANG ZHOU, SULI LI, WENLIANG JIA, GANG LV, CHONGLIN SONG, CHUNSHENG KANG & QINGYU ZHANG. (2015) Effects of diesel exhaust particles on microRNA-21 in human bronchial epithelial cells and potential carcinogenic mechanisms. Molecular Medicine Reports 12:2, pages 2329-2335.
Crossref
Bing Feng, Kai Zhang, Rui Wang & Longbang Chen. (2015) Non-small-cell lung cancer and miRNAs: novel biomarkers and promising tools for treatment. Clinical Science 128:10, pages 619-634.
Crossref
Xingli Zhu, Guanghui Gao, Kaili Chu, Xiufang Yang, Shengxiang Ren, Yao Li, Hai Wu, Yan Huang & Caicun Zhou. (2015) Inhibition of RAC1-GEF DOCK3 by miR-512-3p contributes to suppression of metastasis in non-small cell lung cancer. The International Journal of Biochemistry & Cell Biology 61, pages 103-114.
Crossref
Zhenhua Yang, Surong Fang, Yicheng Di, Weiwei Ying, Yan Tan & Wei Gu. (2015) Modulation of NF-?B/miR-21/PTEN Pathway Sensitizes Non-Small Cell Lung Cancer to Cisplatin. PLOS ONE 10:3, pages e0121547.
Crossref
Li-Min Xu, Li-Qin Li, Jing Li, Hong-Wei Li, Qi-Bin Shen, Jin-Liang Ping, Zhi-Hong Ma, Jing Zhong & Li-Cheng Dai. (2015) Upregulation of MiR-1280 Expression in Non-small Cell Lung Cancer Tissues. Chinese Medical Journal 128:5, pages 670-673.
Crossref
Lauren MacDonagh, Steven G. Gray, Stephen P. Finn, Sinead Cuffe, Kenneth J. O’Byrne & Martin P. Barr. (2015) The emerging role of microRNAs in resistance to lung cancer treatments. Cancer Treatment Reviews 41:2, pages 160-169.
Crossref
Monica Miozzo, Valentina Vaira & Silvia Maria Sirchia. (2015) Epigenetic alterations in cancer and personalized cancer treatment. Future Oncology 11:2, pages 333-348.
Crossref
Athina Markou, Ioanna Sourvinou, Ioanna Balkouranidou & Evi S. Lianidou. 2015. Biomarkers in Cancer. Biomarkers in Cancer 325 344 .
Valerio Del Vescovo & Michela A. Denti. 2015. microRNA: Cancer. microRNA: Cancer 153 177 .
Fang-ling Ning, Feng Wang, Mian-li Li, Ze-shun Yu, Yan-zhang Hao & Shao-shui Chen. (2014) MicroRNA-182 modulates chemosensitivity of human non-small cell lung cancer to cisplatin by targeting PDCD4. Diagnostic Pathology 9:1.
Crossref
Júlia L.F. Abrantes, Thaís F. Tornatore, Karin J. Pelizzaro-Rocha, Marcelo B. de Jesus, Rodrigo T. Cartaxo, Renato Milani & Carmen V. Ferreira-Halder. (2014) Crosstalk between kinases, phosphatases and miRNAs in cancer. Biochimie 107, pages 167-187.
Crossref
Qin Ru, Xiang Tian, Ming‑Shan Pi, Lin Chen, Kai Yue, Qi Xiong, Bao‑Miao Ma & Chao‑Ying Li. (2014) Voltage‑gated K+ channel blocker quinidine inhibits proliferation and induces apoptosis by regulating expression of microRNAs in human glioma U87‑MG cells. International Journal of Oncology.
Crossref
Biagio Ricciuti, Carmen Mecca, Lucio Crinò, Sara Baglivo, Matteo Cenci & Giulio Metro. (2014) Non-coding RNAs in lung cancer. Oncoscience 1:11, pages 674-705.
Crossref
Yang Zhao, Qingyi Wei, Lingming Hu, Feng Chen, Zhibin Hu, Rebecca S. Heist, Li Su, Christopher I. Amos, Hongbing Shen & David C. Christiani. (2014) Polymorphisms in MicroRNAs Are Associated with Survival in Non–Small Cell Lung Cancer. Cancer Epidemiology, Biomarkers & Prevention 23:11, pages 2503-2511.
Crossref
Ren-Tao Wang, Meng Xu, Cheng-Xiong Xu, Zhi-Gang Song & Hua Jin. (2014) Decreased Expression of miR216a Contributes to Non–Small-Cell Lung Cancer Progression. Clinical Cancer Research 20:17, pages 4705-4716.
Crossref
Wenjie Zhu & Binghe Xu. (2014) MicroRNA-21 Identified as Predictor of Cancer Outcome: A Meta-Analysis. PLoS ONE 9:8, pages e103373.
Crossref
Chao Zhang, Ya-Ran Shi, Xiao-Ran Liu, Yong-Chun Cao, Jin-Ling Tian, Zi-Ye Jia, Di Zhen, Feng-Hua Liu & Jian-Ming Gao. (2014) The regulatory role of icariin on apoptosis in mouse preimplantation embryos with reduced microRNA-21. Theriogenology 82:3, pages 461-468.
Crossref
W. Zhang, W. Bai & W. Zhang. (2013) MiR-21 suppresses the anticancer activities of curcumin by targeting PTEN gene in human non-small cell lung cancer A549 cells. Clinical and Translational Oncology 16:8, pages 708-713.
Crossref
Hua Shen, Fang Zhu, Jinyuan Liu, Tongpeng Xu, Dong Pei, Rong Wang, Yingying Qian, Qi Li, Lin Wang, Zhumei Shi, Jitai Zheng, Qiudan Chen, Binghua Jiang & Yongqian Shu. (2014) Alteration in Mir-21/PTEN Expression Modulates Gefitinib Resistance in Non-Small Cell Lung Cancer. PLoS ONE 9:7, pages e103305.
Crossref
Xin Zhou, Xiaping Wang, Zebo Huang, Jian Wang, Wei Zhu, Yongqian Shu & Ping Liu. (2014) Prognostic Value of miR-21 in Various Cancers: An Updating Meta-Analysis. PLoS ONE 9:7, pages e102413.
Crossref
Wen Gao, Lingxiang Liu, Jing Xu, Qianwen Shao, Yiqian Liu, Huazong Zeng & Yongqian Shu. (2014) A systematic analysis of predicted MiR-31-targets identifies a diagnostic and prognostic signature for lung cancer. Biomedicine & Pharmacotherapy 68:4, pages 419-427.
Crossref
Hua Shen, Jinyuan Liu, Rong Wang, Xu Qian, Ruitong Xu, Tongpeng Xu, Qi Li, Lin Wang, Zhumei Shi, Jitai Zheng, Qiudan Chen & Yongqian Shu. (2014) Fulvestrant increases gefitinib sensitivity in non-small cell lung cancer cells by upregulating let-7c expression. Biomedicine & Pharmacotherapy 68:3, pages 307-313.
Crossref
Xia Xiao, Shaorong Yu, Shuchun Li, Jianzhong Wu, Rong Ma, Haixia Cao, Yanliang Zhu & Jifeng Feng. (2014) Exosomes: Decreased Sensitivity of Lung Cancer A549 Cells to Cisplatin. PLoS ONE 9:2, pages e89534.
Crossref
Pooja Joshi. (2014) MicroRNA in lung cancer. World Journal of Methodology 4:2, pages 59.
Crossref
Valerio Del Vescovo. (2014) MicroRNAs as lung cancer biomarkers. World Journal of Clinical Oncology 5:4, pages 604.
Crossref
Thiago de O. Araujo, Lilian T. Costa, Janaina Fernandes, Ricardo Queiroz Aucélio & Reinaldo Calixto de Campos. (2014) Biomarkers to assess the efficiency of treatment with platinum-based drugs: what can metallomics add?. Metallomics 6:12, pages 2176-2188.
Crossref
Athina Markou, Ioanna Sourvinou, Ioanna Balkouranidou & Evi S. Lianidou. 2014. Biomarkers in Cancer. Biomarkers in Cancer 1 16 .
Zhaohui Gong, Zhuo Dong, Lihua Yang, Jie Yang, Jingqiu Li, Yanping Le, Shaomin Wang, Meng Ye & Hui-Kuan Lin. 2014. MicroRNA Targeted Cancer Therapy. MicroRNA Targeted Cancer Therapy 51 82 .
Duaa Dakhallah, Melissa Piper & S. Patrick Nana-Sinkam. 2014. Non-coding RNAs and Cancer. Non-coding RNAs and Cancer 265 282 .
Lin Wu, Gang Li, Dayun Feng, Huaizhou Qin, Li Gong, Jian Zhang & Zhiguo Zhang. (2013) MicroRNA-21 expression is associated with overall survival in patients with glioma. Diagnostic Pathology 8:1.
Crossref
Kenneth KW To. (2013) MicroRNA: a prognostic biomarker and a possible druggable target for circumventing multidrug resistance in cancer chemotherapy. Journal of Biomedical Science 20:1.
Crossref
Yan Li, Li Li, Yan Guan, Xiuju Liu, Qingyong Meng & Qisen Guo. (2013) MiR-92b regulates the cell growth, cisplatin chemosensitivity of A549 non small cell lung cancer cell line and target PTEN. Biochemical and Biophysical Research Communications 440:4, pages 604-610.
Crossref
Shi‐Yun Cui, Rui Wang & Long‐Bang Chen. (2013) MicroRNAs: key players of taxane resistance and their therapeutic potential in human cancers. Journal of Cellular and Molecular Medicine 17:10, pages 1207-1217.
Crossref
Wen-Cheng Zhang, Jinbo Liu, Xiangying Xu & Guangshun Wang. (2013) The role of microRNAs in lung cancer progression. Medical Oncology 30:3.
Crossref
S. Klebe & D.W. Henderson. (2013) Facts and fiction: premalignant lesions of lung tissues. Pathology 45:3, pages 305-315.
Crossref
Haiyan Si, Xiaoming Sun, Yingjian Chen, Yuan Cao, Shimin Chen, Huanchun Wang & Chengjin Hu. (2012) Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer. Journal of Cancer Research and Clinical Oncology 139:2, pages 223-229.
Crossref
S P Nana-Sinkam & C M Croce. (2012) Clinical Applications for microRNAs in Cancer. Clinical Pharmacology & Therapeutics 93:1, pages 98-104.
Crossref
Wenyu Zhang & Bairong Shen. 2013. Bioinformatics for Diagnosis, Prognosis and Treatment of Complex Diseases. Bioinformatics for Diagnosis, Prognosis and Treatment of Complex Diseases 153 167 .
George M. Yousef, Nicole M. A. White & Andrew H. Girgis. 2013. Cancer Genomics. Cancer Genomics 185 217 .
Cheng-Ming Hsu, Pai-Mei Lin, Yu-Ming Wang, Zong-Jyun Chen, Sheng-Fung Lin & Ming-Yu Yang. (2012) Circulating miRNA is a novel marker for head and neck squamous cell carcinoma. Tumor Biology 33:6, pages 1933-1942.
Crossref
Elisa Giovannetti, Francesca Toffalorio, Tommaso De Pas & Godefridus J Peters. (2012) Pharmacogenetics of conventional chemotherapy in non-small-cell lung cancer: a changing landscape?. Pharmacogenomics 13:9, pages 1073-1086.
Crossref
Xue-Lei Ma, Lei Liu, Xiao-Xiao Liu, Yun Li, Lei Deng, Zhi-Lan Xiao, Yan-Tong Liu, Hua-Shan Shi & Yu-Quan Wei. (2012) Prognostic Role of MicroRNA-21 in Non-small Cell Lung Cancer: a Meta-analysis. Asian Pacific Journal of Cancer Prevention 13:5, pages 2329-2334.
Crossref
Yun Wu, Wenrui Duan, Gregory A Otterson, L James Lee & S Patrick Nana-Sinkam. (2012) Research Highlights. Personalized Medicine 9:3, pages 329-332.
Crossref
Adrian T. Billeter, Rebecca E. Barnett, Devin Druen, Hiram C. PolkJrJr & Victor H. van Berkel. (2012) MicroRNA as a New Factor in Lung and Esophageal Cancer. Seminars in Thoracic and Cardiovascular Surgery 24:3, pages 155-165.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.